Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
GenomOncology logo — Together, we set the bar for cancer care.

GenomOncology

Together, we set the bar for cancer care.

Founded 2012 United States Cleveland, United States 56 employees Debt Financing Total: $2.89M Analytics, Biotechnology +1

General Information

Company Name GenomOncology
Founded Year 2012
Location United States Cleveland, United States
Employees 56
Industries Analytics, Biotechnology, Health Care
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with GenomOncology. To contact GenomOncology, visit genomoncology.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does GenomOncology compare?

A PDF of GenomOncology and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting GenomOncology soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About GenomOncology

GenomOncology, founded in 2012, is a pioneering company in the fields of Analytics, Biotechnology, and Health Care. With the slogan "Together, we set the bar for cancer care," GenomOncology is dedicated to providing the healthcare community with data-driven insights aimed at improving cancer care. By effectively transforming previously unusable data into actionable oncology treatment options and strategic insights, GenomOncology empowers precision oncology programs to achieve measurable results. The company's headquarters is located in the United States. In its latest funding round on 22 November 2019, GenomOncology secured a significant $1.39M in Debt Financing. This investment bolsters the company's potential for further growth within the healthcare technology sector.

Business keywords: precision oncology, data-driven insights, cancer care, precision medicine, oncology treatment options, healthcare community, data transformation, clinical decision support, Molecular Tumor Board workflows, venture backed, Cleveland, OH, assay validation, collaborative decision support

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $1.39M -
22 Nov 2019
Venture Round Undisclosed 3
North Coast Ventures Tri-Star Health Partners Zapis Capital Group
North Coast Ventures, Tri-Star Health Partners +1
05 Feb 2014
Seed Round $250.00K 2
JumpStart North Coast Ventures
JumpStart, North Coast Ventures
06 Jun 2012
Seed Round $1.25M -
01 Apr 2012

GenomOncology Alternatives & Competitors

View All Alternatives
GenomOncology vs
OncoDNA
OncoDNA Belgium

Genomic and theranostic company specializing in precision medicine for the treatment of cancer and g...

Series C
52 employees
Biotechnology, Health Care
Compare GenomOncology vs OncoDNA
GenomOncology vs
Agendia
Agendia United States

MammaPrint® + BluePrint® provides you with actionable insights throughout your patient’s breast canc...

Private Equity
209 employees
Biotechnology, Health Care
Compare GenomOncology vs Agendia
GenomOncology vs
ACT Genomics
ACT Genomics Taiwan

Make Personalized Medicine Accessible To All.

Venture round
121 employees
Biotechnology, Health Care
Also compare with: GenomOncology vs CureMatch, Inc. CureMatch, Inc. View all alternatives

FAQ About GenomOncology

Together, we set the bar for cancer care.
GenomOncology was founded in 2012.
GenomOncology is headquartered in Cleveland, United States.
GenomOncology operates in Analytics, Biotechnology and Health Care. Its work centres on precision oncology, data-driven insights, cancer care and precision medicine.
GenomOncology has approximately 56 employees.
GenomOncology has completed 4 funding rounds, raising a total of $2.89M. The latest funding stage is Debt Financing.
Top alternatives and competitors to GenomOncology include OncoDNA, Agendia, ACT Genomics, hc1, Genomate Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GenomOncology and OncoDNA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GenomOncology, https://bouncewatch.com/company/genomoncology, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout